[go: up one dir, main page]

ZA86433B - Novel treatment - Google Patents

Novel treatment

Info

Publication number
ZA86433B
ZA86433B ZA86433A ZA86433A ZA86433B ZA 86433 B ZA86433 B ZA 86433B ZA 86433 A ZA86433 A ZA 86433A ZA 86433 A ZA86433 A ZA 86433A ZA 86433 B ZA86433 B ZA 86433B
Authority
ZA
South Africa
Prior art keywords
novel treatment
novel
treatment
Prior art date
Application number
ZA86433A
Other languages
English (en)
Inventor
Jonathan Robert Sanders Arch
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of ZA86433B publication Critical patent/ZA86433B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA86433A 1985-01-21 1986-01-02 Novel treatment ZA86433B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB858501488A GB8501488D0 (en) 1985-01-21 1985-01-21 Treatment

Publications (1)

Publication Number Publication Date
ZA86433B true ZA86433B (en) 1986-12-30

Family

ID=10573171

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA86433A ZA86433B (en) 1985-01-21 1986-01-02 Novel treatment

Country Status (6)

Country Link
EP (1) EP0195496A3 (da)
JP (1) JPS61180785A (da)
AU (1) AU5253486A (da)
DK (1) DK31386A (da)
GB (1) GB8501488D0 (da)
ZA (1) ZA86433B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650400A (en) * 1984-03-26 1987-03-17 David Constant V Helicopter blade pitch adjusting system
GB8621870D0 (en) * 1986-09-11 1986-10-15 Beecham Group Plc Active compounds
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5196429A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5272153A (en) * 1986-12-31 1993-12-21 Hoechst-Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5196430A (en) * 1986-12-31 1993-03-23 Hoechst-Roussel Pharmaceuticals Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5021422A (en) * 1989-06-08 1991-06-04 Senetek Plc Method and composition for treating hyperproliferative skin diseases using 6-aminopurine cytokinins
JPH06508842A (ja) 1991-07-05 1994-10-06 ビイク グルデン ロンベルク ヒエーミツシエ フアブリーク ゲゼルシヤフト ミツト ベシユレンクテル ハフツング 置換ピリダジンの皮膚病に対する使用
IL99368A (en) * 1991-09-02 1996-01-19 Teva Pharma Preparations for the treatment of psoriasis and atopic dermatitis, which contain the result of xanthine
WO2001070889A2 (en) * 2000-03-22 2001-09-27 Bemis Manufacturing Company Flame-resistant-thermoset coating

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6507877A (da) * 1965-06-18 1966-12-19
FR2235678A1 (en) * 1973-07-02 1975-01-31 Merck & Co Inc Topical antipsoriasis agents - contg. prostaglandin E1 or E2
LU71047A1 (da) * 1974-10-03 1975-06-24
US4144332A (en) * 1976-01-05 1979-03-13 The Regents Of The University Of Michigan Process for alleviating proliferative skin diseases
US4061753A (en) * 1976-02-06 1977-12-06 Interx Research Corporation Treating psoriasis with transient pro-drug forms of xanthine derivatives
EP0005015B1 (en) * 1978-04-22 1986-10-29 BEECHAM - WUELFING GmbH & Co. KG Use of a xanthine derivate in the manufacture of a medicament
DE2929596A1 (de) * 1979-07-21 1981-02-05 Hoechst Ag Verfahren zur herstellung von oxoalkyl-xanthinen
EP0157098A1 (en) * 1980-06-21 1985-10-09 Beecham Wuelfing GmbH & Co KG Xanthine derivatives, pharmaceuticals compositions containing them and a process for their preparation
US4341783A (en) * 1980-07-31 1982-07-27 Lemmon Company Topical use of dyphylline and dyphylline containing compositions

Also Published As

Publication number Publication date
EP0195496A3 (en) 1990-01-17
GB8501488D0 (en) 1985-02-20
JPS61180785A (ja) 1986-08-13
AU5253486A (en) 1986-07-24
DK31386A (da) 1986-07-22
DK31386D0 (da) 1986-01-21
EP0195496A2 (en) 1986-09-24

Similar Documents

Publication Publication Date Title
ZA859286B (en) Novel treatment
GB8419516D0 (en) Treatment
GB8419515D0 (en) Treatment
GB8513369D0 (en) Treatment
PT84294A (en) Novel treatment
GB8412049D0 (en) Treatment
GB8418430D0 (en) Treatment
ZA86433B (en) Novel treatment
GB8515845D0 (en) Treatment
GB8531608D0 (en) Treatment
GR862004B (en) Novel treatment
GB8525202D0 (en) Treatment
GB8520651D0 (en) Treatment
GB8509039D0 (en) Treatment
GB8519306D0 (en) Treatment
GB8531614D0 (en) Treatment
GB8512908D0 (en) Treatment
GB8528807D0 (en) Treatment
GB8527994D0 (en) Treatment
GB8512451D0 (en) Treatment
GB8513551D0 (en) Treatment
GB8513368D0 (en) Treatment
GB8524349D0 (en) Treatment
GB8522582D0 (en) Treatment
GB8516269D0 (en) Treatment